MAJOR UPDATE: The latest Senate Labor and Health and Human Services Appropriations Bill would instruct the Secretary of HHS to prioritize consideration of deceased donor islet (DDI) reclassification. If passed, the explanatory statement that accompanies the bill makes clear Congress' preference for HHS to reclassify DDIs as organs to increase access to transplants.
Stay tuned for other good T1D news from the draft appropriations bill. #SeeT1D#T1D#Type1
Two weeks left to apply! ⏰
! #BreakthroughT1DCC27#SeeT1DApplications for Breakthrough T1D 2027 Children's Congress close November 30. Don't miss your chance to make a difference for everyone living with T1D. The event takes place June 28 - July 1 - apply now atcc.BreakthroughT1D.org
T1D is taking over Times Square! 🗽💙
This #WorldDiabetesDay, we're putting the type 1 diabetes (T1D) community in the spotlight and celebrating their strength, stories, and resilience on one of the world's biggest stages!
From Peloton Head Instructor and Project Swagger Host Robin Arzón, to 2025 U.S. Open and 3x PGA Tour Champion J.J. Spaun, to Katie Beth Hand, who has been insulin-free following an islet transplant and investigational therapy in a Breakthrough T1D-funded clinical trial to incredible community advocates Delilah, Calder, Campbell and their families we're proud to share the stories of the T1D community.
Today, we invite you to see the entire T1D community and the cures we're pursuing for everyone impacted. Each face tells a unique story of courage, strength, and hope. Together, they represent the millions of people and families impacted by T1D every day. Their stories remind us that T1D looks different for everyone, every experience deserves to be seen, and every breakthrough brings us closer to a world without T1D.
A huge thank you to OUTFRONT for their partnership and donating this media space in Times Square.
Learn more at SeeT1D.org.
#WorldDiabetesDay#SeeT1D#BreakthroughT1D#Type1Diabetes
Big news for the T1D community! 💙
This National Diabetes Awareness Month, we're proud to join forces with @Walgreens and the Walgreens Foundation to help families impacted by type 1 diabetes (T1D) stay healthy today as we work toward cures for tomorrow.
For people living with T1D, pharmacies play an essential role in everyday life, providing access to life-sustaining insulin, supplies, and support.
Thanks to a generous commitment over three years from the Walgreens Foundation, we're working together to bring more resources, education, and support to communities across America.
Healthy today. Cures tomorrow.
Learn more at breakthrought1d.org/for-the-….
"The thing that changed my life the most was never going low."
Katie Beth Hand was diagnosed with T1D at age 26 and spent years struggling with severe hypoglycemia. In January 2026, she enrolled in a Breakthrough T1D-funded clinical trial studying Eledon’s tegoprubart at the University of Chicago.
Today, she is insulin-free.
Watch Katie Beth's full conversation with our CEO to hear her story and learn more about the research that is helping advance the future of T1D treatment. youtube.com/watch?v=SLCLTYjs…
"Our central recommendation, which we first presented to Secretary Kennedy on March 6, 2026, is that HHS define unmodified DDI as organs under the National Organ Transplant Act (NOTA), so that this therapy is overseen through HRSA and the Organ Procurement and Transplantation Network (OPTN), while FDA retains jurisdiction over manufactured cell therapies and modified DDI."
Read the full submission here: breakthrought1d.org/news-and…#Nationaldiabetesawarenessmonth#T1D
Today @BreakthroughT1D submitted our response to the Department of Health and Human Services' Request for Information on Deceased Donor Islet Classifications. SVP of Global Advocacy Campbell Hutton explains our approach, where we are in the process, and what we'll do to keep progress moving.
November is National Diabetes Awareness Month (NDAM), and it’s a great time to share your story, spread awareness about type 1 diabetes (T1D), and help people around the world #SeeT1D.
T1D impacts over 9.5 million people around the world across every age, background, and community. Behind every statistic is a real person, a family, and a story that deserves to be seen and understood.
Learn more at SeeT1D.org
Breakthrough T1D’s first-ever Clinical & Research Congress (CRC 2026), focused entirely on type 1 diabetes (T1D), wrapped up just over two weeks ago! To check out all our coverage from the exciting weekend in Philadelphia, PA, where researchers, clinicians, industry leaders, healthcare professionals (HCPs), and the T1D community united to share updates across our entire mission, click here: bit.ly/4irsdNE
Thanks for joining us throughout our coverage of our Clinical & Research Congress! And thank you to everyone who helped make this conference possible, including our sponsors, donors, supporters, and staff. We couldn’t do this without you.
We couldn’t be more proud of how our inaugural conference turned out, and we’re already looking forward to next year. Mark your calendars: CRC 2027 will take place in Washington, D.C., from October 15-17, 2027!
Anyone who runs a marathon has something driving them for all 26.2 miles of their race. For Emily, that’s her daughter, Kendall, who lives with type 1 diabetes (T1D). Emily is running the New York City Marathon next Sunday with Breakthrough T1D to help us continue to power breakthroughs in T1D research!
Want to learn more about running with Breakthrough T1D? Visit the link below!
bit.ly/4iy7LM5
There is something special about a Breakthrough T1D Walk! Walk day unites our community to accelerate life-changing type 1 diabetes (T1D) research, and provides an opportunity to connect with other people living with and impacted by T1D, and so much more!
To find a walk near you, visit walk.breakthrought1d.org!
Katie Beth Hand took part in a Breakthrough T1D-funded clinical trial of an investigational immune therapy for type 1 diabetes tested with an islet transplant, and she’s been off insulin for over 200 days.
DA Gros, M.D., is the CEO of Eledon, the company that developed that investigational therapy, called tegoprubart.
Here, with Lynn Starr, Breakthrough T1D Chief Global Advocacy Officer, they meet face to face for the first time.
See an excerpt for their conversation about life post-islet transplant, the work behind the breakthroughs, and the pathway to therapies that will one day allow everyone to take off their pumps and CGMs for good and watch the full conversation here: bit.ly/3VPUqWK
A new clinical trial for Eledon Pharmaceutical's tegoprubart is underway — and the first participant with type 1 diabetes (T1D) and reduced kidney function has received their islet transplant!
Breakthrough T1D is funding a clinical trial at the University of Chicago and the University of Miami that replaces tacrolimus, a traditional immunosuppressant, with tegoprubart, a milder and more targeted alternative, in islet transplants for people with T1D and reduced kidney function. Tacrolimus can damage the kidneys and the transplanted islet cells, so people with reduced kidney function have previously been excluded from these transplants.
Nearly a third of people with T1D will develop kidney disease. This study could open islet transplants to a larger population of people with T1D.
Learn more here: breakthrought1d.org/news-and…
Day 2 of our Clinical Research Congress brought incredible conversations surrounding global collaboration, unmet needs for those in the type 1 diabetes (T1D) community, disease modifying therapies, and more. We are extremely thankful to have so many brilliant minds together in one place helping move us toward cures and improving lives for everyone living with T1D. Click here for the full recap: breakthrought1d.org/news-and…